<?xml version="1.0" encoding="UTF-8"?>
<p>Among elderly patients of ≥65 years of age, the sensitivity and specificity of ImunoAce Flu for influenza A virus were 96.6% (95%CI: 90.3–99.3) and 93% (95%CI: 85.4–97.4), respectively. In contrast, in adults of &lt;65 years of age, the sensitivity and specificity were 97.5% (95%CI: 92.9–99.5) and 86.3% (95%CI: 78.7–92.0), respectively (
 <xref rid="pone.0231217.t001" ref-type="table">Table 1</xref>). However, there was no significant difference in specificity between the ≥65 years and &lt;65 years age groups (p = 0.757).
</p>
